Cardiogenics Stock Price, News & Analysis
Company Description
Cardiogenics (OTC Link: CGNH) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $1.9M.
CGNH stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of CGNH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardiogenics (CGNH) stock last traded at $0.0001. At a market capitalization of $1.9M, CGNH is classified as a micro-cap stock with approximately 96.1M shares outstanding.
Latest News
Cardiogenics has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include dividends. View all CGNH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CGNH Company Profile & Sector Positioning
Cardiogenics (CGNH) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CGNH often look at related companies in the same sector, including Centogene N.V. (CNTGF), Invitro Internat (IVRO), Leveljump Health (JMPHF), Imd Companies (ICBU), and Interpace Biosciences Inc (IDXG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CGNH's relative position within its industry.